Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
JUUL Addiction Cases To Be Prepared For Early Trial Dates, Likely Beginning in February 2022 September 1, 2020 Irvin Jackson Add Your Comments The U.S. District Judge presiding over all JUUL addiction lawsuits indicates that the first bellwether trial is likely to go before a jury in February 2022. There are currently more than 900 product liability complaints filed throughout the federal court system, each involving claims that teens and young adults have been left with nicotine addiction problems from JUUL vaping pods. According to allegations raised in the litigation, false and misleading advertisements for JUUL specifically targeted teens and prior non-smokers, creating a new generation of Americans addicted to nicotine. In addition to the individual addiction claims, a number of class action lawsuits have also been filed on behalf of school districts and other entities that have incurred damages that resulted from the nationwide vaping epidemic that has plagued the U.S. in recent years. LEARN MORE ABOUT VAPE PEN AND E-CIG LAWSUITS Serious lung injuries, respiratory illnesses, and nicotine addiction have been linked to a wide range of vaping products, including e-cigarettes and THC vape pens. Lawsuits are being pursued against manufacturers for failing to warn users about these risks. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About VAPE PEN AND E-CIG LAWSUITS Serious lung injuries, respiratory illnesses, and nicotine addiction have been linked to a wide range of vaping products, including e-cigarettes and THC vape pens. Lawsuits are being pursued against manufacturers for failing to warn users about these risks. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Given similar questions of fact and law presented in complaints filed throughout the federal court system, the litigation is currently centralized before U.S. District Judge William H. Orrick III in the U.S. District Court for the Northern District of California, which is where JUUL Labs, Inc.’s San Francisco headquarters are located. According to minutes (PDF) from a status conference held on August 21, Judge Orrick indicates that while the Court had hoped to start the first JUUL bellwether trials by the end of 2021, the COVID-19 pandemic and other scheduling issues means that the first trial date is more likely to start in February 2022. While plaintiffs had proposed holding the first bellwether trial in December 2021, While Judge Orrick indicated that he was inclined to accept much of a proposal submitted by plaintiffs regarding the selection for bellwether cases, he was unable to approve the proposal for the first bellwether trial to begin in December 2021. However, he noted the Court still had to review details of the proposal further before issuing a final order. The plaintiffs’ proposal, detailed in part in a joint case management conference statement (PDF) submitted on August 20, calls for the class action and individual lawsuits to go through discovery in parallel, with the first trials involving individual addiction cases. “Recognizing that discovery is largely common to all types of cases, Plaintiffs are developing each type of case alongside the others, sharing resources, and methodically spreading tasks,” the proposal states. “The goal of this approach is efficiency.” While discovery progress has been made, and depositions are being conducted remotely, the plaintiffs note that the court should not wait until the current COVID-19 pandemic and associated delays are resolved, since there is no indication of when that will occur. JUUL Teen Addiction Problems As JUULing addiction lawyers continue to review and file claims for teens and young adults in the coming months and years, the litigation is expected to continue to grow, likely to include thousands of complaints against the manufacturer fo the controversial vaping pod. Plaintiffs allege JUUL products were intentionally designed to look like a USB thumb drive, which has made the product popular among teems who are able to hide their vaping habit from parents, teachers and other adults. In addition, the manufacturer sold JUUL pods in various candy-like flavors, without disclosing the high levels of nicotine and risk of addiction. JUUL Labs has been accused of fueling the teen e-cigarette epidemic in the United States, resulting in new generation now addicted to nicotine. As part of the consolidation into a MDL, Judge Orrick indicates he will establish a “bellwether” process, where a small group of representative claims will be prepared for early trial dates to help the parties gauge how juries are likely to respond to certain evidence and testimony that will be repeated throughout the litigation. However, if the manufacturer fails to reach JUUL settlements or another resolution for the claims following the consolidated pretrial proceedings, each individual case may be remanded back to U.S. District Courts nationwide for individual trials in the future. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Children, Drug Addiction, Electronic Cigarettes, Juul, Nicotine, Vaping More JUUL E-Cigarette Vape Lawsuit Stories More Than Half of U.S. Teens Who Vape Do So To Deal With Stress, Anxiety: Study November 18, 2024 On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024 Vaping Causes Same DNA Damage as Smoking, Study Finds April 12, 2024 0 Comments PhoneThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: 4 days ago) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025) Ongoing Cartiva Lawsuit Settlement Negotiations Cited as Reason to Reject MDL Consolidation (Posted: 5 days ago) Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Lawsuits Allege Toe Implant Fails in About 64% of Patients (11/12/2025)MDL Sought for Cartiva Implant Lawsuits Filed in Federal Court System (11/03/2025)Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant (09/18/2025) Covidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 (Posted: 6 days ago) The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution. MORE ABOUT: HERNIA MESH LAWSUITFeb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge (11/05/2025)Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications (09/08/2025)Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 (08/21/2025)
On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024
Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: 4 days ago) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)
Ongoing Cartiva Lawsuit Settlement Negotiations Cited as Reason to Reject MDL Consolidation (Posted: 5 days ago) Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Lawsuits Allege Toe Implant Fails in About 64% of Patients (11/12/2025)MDL Sought for Cartiva Implant Lawsuits Filed in Federal Court System (11/03/2025)Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant (09/18/2025)
Covidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 (Posted: 6 days ago) The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution. MORE ABOUT: HERNIA MESH LAWSUITFeb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge (11/05/2025)Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications (09/08/2025)Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 (08/21/2025)